Anti-atherosclerotic and anti-diabetic properties of probucol and related compounds (Q37109628)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2008

Language	Label	Description	Also known as
English	Anti-atherosclerotic and anti-diabetic properties of probucol and related compounds	scientific article published on January 2008

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

Anti-atherosclerotic and anti-diabetic properties of probucol and related compounds (English)

1 reference

Europe PubMed Central

18 August 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

3

object named as

Roland Stocker

1 reference

Europe PubMed Central

18 August 2017

2

object named as

Neil Hime

1 reference

Europe PubMed Central

18 August 2017

author name string

David Tanous

1

1 reference

Europe PubMed Central

18 August 2017

publication date

1 January 2008

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

13

1 reference

Europe PubMed Central

18 August 2017

2

1 reference

Europe PubMed Central

18 August 2017

48-59

1 reference

Europe PubMed Central

18 August 2017

Role of oxidative modifications in atherosclerosis

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Facing the diabetes epidemic--mandatory reporting of glycosylated hemoglobin values in New York City

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Prevalence of overweight and obesity in the United States, 1999-2004

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Effects of torcetrapib in patients at high risk for coronary events

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Probucol inhibits oxidative modification of low density lipoprotein

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST).

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Effect of probucol on repeat revascularization rate after percutaneous transluminal coronary angioplasty (from the Probucol Angioplasty Restenosis Trial [PART]).

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Effects of AGI-1067 and probucol after percutaneous coronary interventions.

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agent

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Clinical trials update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY.

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Compensatory enlargement of human atherosclerotic coronary arteries

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Probucol promotes functional reendothelialization in balloon-injured rabbit aortas

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Probucol protects against smooth muscle cell proliferation by upregulating heme oxygenase-1.

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Probucol inhibits in-stent thrombosis and neointimal hyperplasia by promoting re-endothelialization.

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Autoimmunity and beta cell regeneration in mouse and human type 1 diabetes: the peace is not enough

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Protective effect of probucol on alloxan diabetes in rats

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Probucol attenuated hyperglycemia in multiple low-dose streptozotocin-induced diabetic mice

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Probucol preserves pancreatic beta-cell function through reduction of oxidative stress in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Probucol delays progression of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Combined effect of probucol and insulin on cataracts of diabetic rats fed a high cholesterol diet

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Probucol and ticlopidine: effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetes

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Probucol inhibits mononuclear cell adhesion to vascular endothelium in the cholesterol-fed rabbit

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M-CSF in the aortic wall of LDL receptor-deficient rabbits during early atherogenesis

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Selective Inhibition of Endothelial and Monocyte Redox-Sensitive Genes by AGI-1067: A Novel Antioxidant and Anti-Inflammatory Agent

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Induction of cellular cholesterol efflux to lipid-free apolipoprotein A-I by cAMP.

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Processes involved in the site-specific effect of probucol on atherosclerosis in apolipoprotein E gene knockout mice.

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Comparison of the effects of alpha-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbits

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Probucol protects against hypochlorite-induced endothelial dysfunction: identification of a novel pathway of probucol oxidation to a biologically active intermediate.

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Presence of hypochlorite-modified proteins in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Association between myeloperoxidase levels and risk of coronary artery disease

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Serum myeloperoxidase levels independently predict endothelial dysfunction in humans.

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Heme oxygenase-1 protects against vascular constriction and proliferation

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Probucol reduces plasma and aortic wall oxysterol levels in cholesterol fed rabbits independently of its plasma cholesterol lowering effect

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits.

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

On the hepatic mechanism of HDL assembly by the ABCA1/apoA-I pathway

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Probucol enhances the expression of human hepatic scavenger receptor class B type I, possibly through a species-specific mechanism

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Probucol enhances selective uptake of HDL-associated cholesteryl esters in vitro by a scavenger receptor B-I-dependent mechanism

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

MDL 29311. Antioxidant with marked lipid- and glucose-lowering activity in diabetic rats and mice.

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Effect of antioxidant probucol for preventing stent restenosis

1 reference

https://api.crossref.org/works/10.1179%2F135100008X259196

21 January 2018

Identifiers

10.1179/135100008X259196

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37109628&oldid=2116608875"